Polo Shirts For Men Black And Red

release upon further developments.

Polo Shirts For Men Black And Red

Polo Shirts For Men Black And Red

Polo Shirts For Men Black And Red

Polo Shirts For Men Black And Red

Cell Therapeutics, Inc. Announces Polo Shirts For Men Black And Red Change of Name to CTI BioPharma Corp. PR Newswire SEATTLE, May 30, 2014 SEATTLE, May 30, 2014 /PRNewswire/ Cell Therapeutics, Inc. (CTI or the Company) (NASDAQ and MTA: CTIC), a Polo Shirts For Girls School

Polo Shirts For Men Black And Red

Polo Shirts For Men Black And Red

Polo Shirts For Men Black And Red

´╗┐Announces Change of Name to CTI BioPharma Corp

in CTI's corporate name. Risks that contribute to the uncertain nature of the forward looking statements include, among others, risks associated with the biopharmaceutical industry in general and with CTI and its product and product candidate portfolio in particular, as well as other risks listed or described from time to time in CTI's most recent filings with the SEC on Forms 10 K, 10 Q and 8 K. Except as required by law, CTI does not intend to update any of the statements in this press Fred Perry Polo Shirts

Polo Shirts For Men Black And Red

Polo Shirts For Men Black And Red

biopharmaceutical company focused on acquiring, developing and bringing to market novel targeted therapies for blood related cancers, today announced that it will change its corporate name to CTI BioPharma Corp. effective May 30, 2014. The Company's common stock will continue to trade under its current ticker symbol: "CTIC." CTI BioPharma Corp. Logo "The rebranding from Cell Therapeutics to CTI BioPharma comes at a defining moment in our company's history and better reflects who we are today and our aspirationsfor becoming a leader in developing therapies for patients with blood related cancers," said James A. "From the beginning, CTI has looked at potential therapies from the patient's perspective to address both the clinical need and the impact treatment can have on a patient's life. This inspires everything we do and is evident in the drugcandidateswe are currently pursuing andthosewe'll look to acquire. Currently, we have a growing commercial presence in Europe for PIXUVRI (pixantrone) for patients withrelapsedaggressive B cell non Hodgkin lymphoma, and a promising late stage pipeline that includes a Phase 3 program forpacritinib, anovelJAK2/FLT3 inhibitor, for patients with myelofibrosis." The change of the company's name will entail, effective May 30, 2014, a change in the CUSIP code associated with CTI shares from 150934883 to 12648L 106, together with a change in the ISIN code associated with CTI shares from US1509348835 to US12648L1061. No action is required by shareholders with respect to this change. The Company will amend its bylaws and file an amendment to CTI's articles of incorporation to reflect the change of the name with the Secretary of State of the State of Washington. The Company's wholly owned European subsidiary, CTI Life Sciences Limited, will remain unchanged. About CTI BioPharma CTI BioPharma Corp. (NASDAQ and MTA: CTIC) is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood related cancers that offer a unique benefit to patients and healthcare providers. The Company has a commercial presence in Europe and a late stage development pipeline, including pacritinib, CTI's lead product candidate that is currently being studied in a Phase 3 program for the treatment of patients with myelofibrosis. CTI BioPharma is headquartered in Seattle, Washington, with offices in London and Milan under the name CTI Life Sciences Limited. Forward Looking Statements This press release includes forward looking statements within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the trading price of CTI's securities. Such statements include, but are not limited to, statements regarding CTI's expectations with respect to the development of CTI and its product and product candidate portfolio, the growth of CTI's commercial presence in Europe for PIXUVRI and the proposed change Custom Made Polo Shirts Uk

Polo Shirts For Men Black And Red

Polo Shirts For Men Black And Red

Lacoste Mens Polo

Beats Pill Pink
Polo Shirts Wholesale Australia

Fred Perry Black T Shirt

Buy Cheap Designer Polo Shirts Online

Polo Shirts For Men Design

Cheap Fred Perry Polo Ebay

Ghd Temperature
Fred Perry Navy Shirt

Us Polo Black T Shirts Online

Lacoste Polo Shirt Uk

Babyliss Straightener Review
Beats By Dre Purple
Lacoste T Shirt

Red Ghds Limited Edition

Home / Polo Shirts For Men Black And Red